StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$0.85+0.04 (+5.13%)

Close on Nov 18, 2026Market cap $109.79MP/E –Yield –

Organogenesis total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Organogenesis's total debt was $49.63M at Dec 31, 2019. For fiscal 2019 it was $49.63M, up 294.6% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$49.63M+294.6%
FY2018Dec 31, 2018$12.58M-15.1%
FY2017Dec 31, 2017$14.82M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2019Dec 31, 2019$49.63M+235.0%
Q2 FY2019Jun 30, 2019$39.66M–
Q1 FY2019Mar 31, 2019$39.64M–
Q4 FY2018Dec 31, 2018$12.58M–
Q4 FY2017Dec 31, 2017$14.82M–

More Organogenesis figures

See a number that looks wrong?